Birdwatch Note
2024-11-28 12:53:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
コロナワクチンが発症入院重症死亡予防効果は勿論のこと、当初、無症状感染の予防効果を持っていた事は、ランダム化比較試験のメタ解析で確認されている事項です。 https://www.carenet.com/news/general/carenet/56042 後遺症予防に関しては、観察研究のメタアナリシスでもオミクロン期に絞ってもわずか(3割程度)に接種者は感染後の症状が続くリスクが低かった事がわかっています(それ以前の変異体での予防効果も勿論、この研究で示されています)。 下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1862044714352177230
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1862117641412116684
- noteId - 1862117641412116684
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1732798416842
- tweetId - 1862044714352177230
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- コロナワクチンが発症入院重症死亡予防効果は勿論のこと、当初、無症状感染の予防効果を持っていた事は、ランダム化比較試験のメタ解析で確認されている事項です。 https://www.carenet.com/news/general/carenet/56042 後遺症予防に関しては、観察研究のメタアナリシスでもオミクロン期に絞ってもわずか(3割程度)に接種者は感染後の症状が続くリスクが低かった事がわかっています(それ以前の変異体での予防効果も勿論、この研究で示されています)。 下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E
Note Ratings
| rated at | rated by | |
| 2024-11-30 21:45:48 -0600 | Rating Details | |
| 2024-11-30 07:03:57 -0600 | Rating Details | |
| 2024-11-29 23:07:47 -0600 | Rating Details | |
| 2024-11-29 04:44:03 -0600 | Rating Details | |
| 2024-11-29 00:47:07 -0600 | Rating Details | |
| 2024-11-29 00:24:45 -0600 | Rating Details | |
| 2024-11-28 21:59:56 -0600 | Rating Details | |
| 2024-11-28 21:06:49 -0600 | Rating Details | |
| 2024-11-28 20:52:16 -0600 | Rating Details | |
| 2024-11-28 20:32:59 -0600 | Rating Details | |
| 2024-11-28 19:39:15 -0600 | Rating Details | |
| 2024-11-28 16:06:58 -0600 | Rating Details | |
| 2024-11-28 15:44:58 -0600 | Rating Details | |
| 2024-11-28 13:19:21 -0600 | Rating Details | |
| 2024-11-28 09:36:34 -0600 | Rating Details | |
| 2024-11-28 08:42:48 -0600 | Rating Details | |
| 2024-11-28 08:04:41 -0600 | Rating Details | |
| 2024-11-28 08:01:53 -0600 | Rating Details | |
| 2024-11-28 07:54:09 -0600 | Rating Details | |
| 2024-11-28 07:43:34 -0600 | Rating Details | |
| 2024-11-28 07:35:00 -0600 | Rating Details | |
| 2024-11-28 07:05:08 -0600 | Rating Details | |
| 2024-11-29 04:55:55 -0600 | Rating Details | |
| 2024-11-29 01:45:12 -0600 | Rating Details | |
| 2024-11-28 18:48:10 -0600 | Rating Details | |
| 2024-11-28 16:47:55 -0600 | Rating Details | |
| 2024-11-28 15:41:54 -0600 | Rating Details | |
| 2024-11-28 11:20:13 -0600 | Rating Details | |
| 2024-11-28 11:05:19 -0600 | Rating Details | |
| 2024-11-28 09:57:44 -0600 | Rating Details | |
| 2024-11-28 09:42:33 -0600 | Rating Details | |
| 2024-11-28 09:08:22 -0600 | Rating Details | |
| 2024-11-28 09:00:50 -0600 | Rating Details | |
| 2024-11-28 08:56:57 -0600 | Rating Details | |
| 2024-11-28 08:16:44 -0600 | Rating Details | |
| 2024-11-28 08:16:27 -0600 | Rating Details | |
| 2024-11-28 07:53:49 -0600 | Rating Details | |
| 2024-11-28 07:43:44 -0600 | Rating Details | |
| 2024-12-08 04:49:50 -0600 | Rating Details | |
| 2024-11-29 03:25:59 -0600 | Rating Details | |
| 2024-11-28 16:50:04 -0600 | Rating Details | |
| 2024-11-28 15:03:53 -0600 | Rating Details | |
| 2024-11-28 09:36:10 -0600 | Rating Details | |
| 2024-11-28 09:33:43 -0600 | Rating Details | |
| 2024-11-28 08:41:49 -0600 | Rating Details | |
| 2024-11-28 08:36:56 -0600 | Rating Details | |
| 2024-11-28 08:31:14 -0600 | Rating Details | |
| 2024-11-28 07:53:58 -0600 | Rating Details | |
| 2024-11-28 07:50:22 -0600 | Rating Details | |
| 2024-11-28 07:36:17 -0600 | Rating Details | |
| 2024-11-28 07:29:47 -0600 | Rating Details | |
| 2024-11-29 01:03:20 -0600 | Rating Details | |
| 2024-11-28 20:50:32 -0600 | Rating Details | |
| 2024-11-28 20:06:31 -0600 | Rating Details | |
| 2024-11-28 18:44:51 -0600 | Rating Details | |
| 2024-11-28 13:15:00 -0600 | Rating Details | |
| 2024-11-28 11:42:52 -0600 | Rating Details | |
| 2024-11-28 08:10:52 -0600 | Rating Details | |
| 2024-11-28 07:55:49 -0600 | Rating Details | |
| 2024-11-28 07:39:05 -0600 | Rating Details | |
| 2024-11-28 07:37:59 -0600 | Rating Details | |
| 2024-11-28 07:31:17 -0600 | Rating Details |